17 results on '"Castellano, D."'
Search Results
2. Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study
3. Sunitinib-induced hypertension in CYP3A4 rs4646437 A-allele carriers with metastatic renal cell carcinoma
4. Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)†
5. Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)
6. Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma
7. Phase II study of sunitinib as first-line treatment of urothelial cancer patients ineligible to receive cisplatin-based chemotherapy: baseline interleukin-8 and tumor contrast enhancement as potential predictive factors of activity
8. The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain
9. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)
10. Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-α as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population
11. Phase-II randomized study of pemetrexed + carboplatin or oxaliplatin, as front-line chemotherapy in patients with locally advanced or metastatic non-small cell lung cancer: 2513
12. A phase-II study of gemcitabine plus oxaliplatin combination as first-line chemotherapy in advanced pancreatic/ductal biliary adenocarcinoma (APBC) administered every 2 weeks: 1469
13. Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors
14. Induction chemotherapy with paclitaxel, cisplatin and 5-fluorouracil for squamous cell carcinoma of the head and neck: long-term results of a phase II trial
15. A phase I/II clinical and pharmacologic study of dose-escalating and dose-sequencing administration of gemcitabine (G) and folinic acid (FA)/fluorouracil (FU) in advanced unresectable pancreatic cancer (APC).
16. Analysis of bi-weekly oxaliplatin + folinic acid (FA) + 5-fluorouracil (FU) in metastatic gastrointestinal (GI) carcinoma.
17. Significant clinical acivity of salvage therapy with vinorelbine (VNR) + folinic acid (FA) + 5-fluoruracil (FU) in heavily and minimally pretreated patients with metastatic breast carcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.